Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Filippo Montemurro

Fondazione del Piemonte per l'Oncologia/Unit of Investigative Clinical Oncology (INCO) and Division of Medical Oncology

Strada Provinciale 142

Km 3.95

10060 Candiolo

Italy

[email]@ircc.it

Name/email consistency: high

[Claim this account]

Affiliations

Fondazione del Piemonte per l'Oncologia/Unit of Investigative Clinical Oncology (INCO) and Division of Medical Oncology, Strada Provinciale 142, Km 3.95, 10060 Candiolo, Italy. 2012
Division of Medical Oncology 1, Piedmont Foundation for Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy. 2012
Divisione Universitaria di Oncologia Medica ed Ematologia, Istituto per la ricerca e la Cura del Cancro, Candiolo (Torino), Italy. 2008 - 2009
Institute for Cancer Research and Treatment (IRCC), Candiolo (TO), Italy. 2007
Institute for Cancer Research and Treatment (IRCC), University Division of Medical Oncology and Hematology, Strada Provinciale 142, Km 3.95, Italy. 2007

References

Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer. Rossi, V., Sarotto, I., Maggiorotto, F., Berchialla, P., Kubatzki, F., Tomasi, N., Redana, S., Martinello, R., Valabrega, G., Aglietta, M., Ponzone, R., Montemurro, F. Oncologist (2012) [Pubmed]
Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients. Montemurro, F., Rossi, V., Cossu Rocca, M., Martinello, R., Verri, E., Redana, S., Adamoli, L., Valabrega, G., Sapino, A., Aglietta, M., Viale, G., Goldhirsch, A., Nolè, F. Cancer (2012) [Pubmed]
Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy. Montemurro, F., Aglietta, M. Endocr. Relat. Cancer (2009) [Pubmed]
Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study. Montemurro, F., Redana, S., Nolè, F., Donadio, M., Jacomuzzzi, M.E., Valabrega, G., Viale, G., Sapino, A., Aglietta, M. BMC. Cancer (2008) [Pubmed]
Does addition of lapatinib to capecitabine improve outcome in women with refractory breast cancer? Montemurro, F., Aglietta, M. Nat. Clin. Pract. Oncol (2007) [Pubmed]
Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity. Montemurro, F., Valabrega, G., Aglietta, M. Expert. Opin. Biol. Ther (2007) [Pubmed]
Recent advances in the medical management of breast cancer: highlights from the 29th San Antonio Breast Cancer Conference San Antonio, TX, USA, 14-17 December 2007. Montemurro, F., Redana, S., Valabrega, G., Aglietta, M. Expert. Opin. Pharmacother (2007) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.